Aardvark Therapeutics AARD Cash Flow Statement (2024-2026)

NASDAQ AARD
$4.36 +0.46 (+11.79%)
As of: Oct 21, 2026 · 11:20 AM EDT
Reported Financials

Aardvark Therapeutics Quarterly Cash Flow Statement

Periods 10 quarters
Latest Jun 2026

Aardvark Therapeutics reported cash from operations of -$17.60M and free cash flow of -$17.60M for the quarter ended Jun 2026, down 78.8% year over year. This cash flow statement covers 10 quarters of results from Mar 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -2.18M-5.45M-4.18M-8.78M-9.31M-14.37M-16.32M-17.60M-21.59M-14.39M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based CompensationStock Comp. 0.07M0.05M0.14M0.17M0.23M0.63M1.50M1.58M2.00M1.95M
Gains from Investment SecuritiesGains Investment -0.11M0.03M-0.09M-0.05M-0.02M-0.01M0.04M-0.02M-0.01M0.00M
Other non-cash itemsOther Non-Cash 0.13M0.01M0.11M0.11M0.08M0.09M0.09M
Change in Working Capital
Change in Account PayablesChange Payables -0.45M0.63M-0.58M1.19M0.65M2.58M-0.61M-2.37M2.42M-2.41M
Change in Accured ExpensesChange Accured Exp. 0.49M0.61M0.29M0.00M1.41M1.81M1.03M2.17M-1.26M-2.88M
Change in Other Operating AssetsOther Assets Change 0.33M0.05M-0.25M0.29M4.36M-0.08M1.31M0.37M0.33M-0.15M
Change in Other Operating LiabilitiesOther Liabilities Change -0.03M-0.03M-0.06M-0.09M-0.05M-0.08M-0.10M-0.10M-0.11M-0.11M
Other Working Capital ChangesOther WC Changes -0.36M-0.08M0.20M-0.38M-4.42M0.00M-1.41M-0.47M-0.44M0.04M
Cash from OperationsCash from Ops. -2.19M-4.22M-3.96M-7.73M-11.39M-9.84M-16.13M-16.81M-18.87M-17.60M
Investing Activities
Capital ExpendituresCapex 0.01M0.09M0.01M0.01M0.09M0.00M
Change in Property, Plant and EquipmentChange in PP&E -0.01M-0.09M-0.01M-0.01M-0.09M0.00M
Purchase of InvestmentsInvestments Purchased 11.89M124.65M4.95M
Sale and Maturity of InvestmentsInvestments Sold 12.03M9.50M29.25M29.25M34.25M28.75M
Cash from Investing ActivitiesCash from Investing -0.01M-0.09M-0.01M-11.90M-112.62M9.41M29.25M24.30M34.25M28.75M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 0.17M0.16M91.19M0.01M0.17M0.27M0.00M0.26M
Net Shares Issued and RepurchasedNet Shares Issued 0.17M0.16M91.19M0.01M0.17M0.27M0.00M0.26M
Net Equity Issued and RepurchasedNet Equity Issued 0.17M0.16M91.19M0.01M0.17M0.27M0.00M0.26M
Other financing activitiesOther financing -0.02M-1.18M-2.31M-0.08M
Cash from Financing ActivitiesCash from Financing 82.94M0.06M-1.01M88.88M-0.07M0.17M0.27M0.00M0.26M
Additional items
Change in Cash -2.20M78.63M-3.90M-20.64M-35.14M-0.51M13.29M7.77M15.39M11.41M
Ending Cash Balance 7.54M86.17M82.28M61.64M26.50M26.00M39.29M47.05M62.44M73.85M
Free Cash FlowFCF -2.20M-4.31M-3.96M-7.73M-11.39M-9.94M-16.13M-16.81M-18.87M-17.60M
Net Cash FlowNCF -2.20M78.63M-3.90M-20.64M-35.14M-0.51M13.29M7.77M15.39M11.41M

Aardvark Therapeutics Cash Flow Statement API

Pull Aardvark Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AARD&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY